2019
DOI: 10.4155/bio-2019-0168
|View full text |Cite
|
Sign up to set email alerts
|

Internal Standards (IS) Monitoring in CROs: Anvisa Perspective

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…It describes the crucial role inspections play in the regulatory process and invites the reader to consider the impact IS response variations can have on bioanalytical data. Alongside this, Gustavo Mendes Lima Santos and Eduardo Fernandes (Brazilian Health Regulatory Agency [ANVISA]; Brasilia, Brazil) discuss the perspective of the ANVISA and their regulation monitoring [9]. Specifically, this article considers requirements regarding IS monitoring in CROs.…”
mentioning
confidence: 99%
“…It describes the crucial role inspections play in the regulatory process and invites the reader to consider the impact IS response variations can have on bioanalytical data. Alongside this, Gustavo Mendes Lima Santos and Eduardo Fernandes (Brazilian Health Regulatory Agency [ANVISA]; Brasilia, Brazil) discuss the perspective of the ANVISA and their regulation monitoring [9]. Specifically, this article considers requirements regarding IS monitoring in CROs.…”
mentioning
confidence: 99%